O GoConqr está de visual novo! Conte para nós o que você achou.

Quiz

Infection Disorders- Clinical Pharmacology 5th Year PMU

Med Student 10 perguntas

Fazer o quiz

Perguntas do quiz (10)

  1. 1Antimicrobial drugs for hepato- biliary infections are
    1. ACeftriaxone (Rocephin)
    2. BGentamycin
    3. CRifampicin (Tubocin)
    4. DDoxyxyclin (Vibramycin)
  2. 2In patients with Gram (+) infections are preferred
    1. AUreidopenicillins
    2. BNarrow spectrum penicillines (Ospen)
    3. CMacrolides
    4. DFirst generation cephalosporines
  3. 3In patients with Gram (-) infections are preferred
    1. AUreidopenicillins
    2. BAminoglycoides
    3. CMacrolides
    4. DFirst generation cephalosporines
  4. 4Antimicrobial drugs with renal excretion are
    1. APenicillins
    2. BQuinolones
    3. CMacrolides
    4. DAminoglycosides
  5. 5The antibiotics of choice for patients with immune deficits are
    1. Abactericidal
    2. Bbacteriostatic
    3. Ccarbapenemes
    4. Dglycopeptides
  6. 6Adverse drug reactions of aminoglycosides are
    1. Aototoxicity
    2. Bnephrotoxicity
    3. Cgastrointestinal problems
    4. Dliver toxicity
  7. 7Adverse drug reactions of tetracyclines are
    1. Aliver damage
    2. Bototoxicity
    3. Cnephrotoxicity
    4. Dteeth and bone damage
  8. 8Adverse drug reactions of quinolones are
    1. Agastro-intestinal
    2. Bdamage of the joints
    3. Cincrease of intraocular pressure
    4. Dprovoke seizures in patients with epilepsy
  9. 9Quinolones are contraindicated for
    1. Apregnant women
    2. Bbreast feeding mothers
    3. Cchildren under 12 years of age
    4. Dpatients with kidney failure
  10. 10Adverse drug reactions of sulfonamides are
    1. Abone-marrow suppression
    2. Ballergy
    3. Ckidney damage in high doses
    4. Dheart failure

Informações

Descrição
Infection Disorders- Clinical Pharmacology 5th Year PMU
Idioma
English
Visualizações
148
Avaliação
Ainda sem avaliações
Avalie este quiz
Avalie este quiz

Fale Conosco

Sobre o que é sua mensagem?

O que você acha do novo visual?

Você gostou?